All Stories

  1. Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD
  2. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  3. Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design
  4. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  5. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  6. World No Tobacco Day: smoking, nicotine and children
  7. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
  8. A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction
  9. ERS and tobacco harm reduction
  10. A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
  11. Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study
  12. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
  13. How do clinical trials on COPD exacerbations evaluate the effect treatments have on patients?
  14. Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
  15. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs [Erratum]
  16. Automated control of oxygen supply by O2matic increases time with proper oxygenation.
  17. The Manchester Respiratory-related Sleep Symptoms scale for patients with COPD: development and validation
  18. Validation of lung density indices by cardiac CT for quantification of lung emphysema
  19. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs
  20. Inhaled corticosteroid containing combinations and mortality in COPD
  21. COPD exacerbation rates with IND/GLY
  22. Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability
  23. Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
  24. Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study
  25. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  26. Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease